Abstract: An isolated and purified lactic acid bacteria is provided, which is Lactobacillus paracasei PS23 (PS23) and its applications in delaying aging process, improving immunomodulatory activity, reducing, preventing or treating allergic and inflammation, preventing or treating a chronic disorder and/or (vi) preventing and/or treating a mood disorder or a neurological condition.
Abstract: Provided is a method of reducing a behavioral abnormality associated with a neurodevelopmental disorder in a subject, including administering to the subject an effective amount of Lactobacillus plantarum subsp. plantarum PS128. Also provided is a composition for preventing or treating a behavioral abnormality associated with a neurodevelopmental disorder in a subject in need thereof.
Abstract: This disclosure provides a method of protecting a subject for exercise that prevents an exercise-related harmful effect and reducing exercise fatigue in the subject to thereby enhance physical performance and promote anti-fatigue and anti-inflammatory effects in the subject.
Abstract: The invention relates to a lactic acid bacterium (LAB), Lactobacillus fermentum PS150, and a bioactive protein produced by the LAB, which has an advantageous effect in improving mood disorder, enhancing cognitive functions in brain and treating or preventing a neurodegenerative disease.
Type:
Grant
Filed:
January 13, 2017
Date of Patent:
September 6, 2022
Assignee:
Bened Biomedical Co., Ltd.
Inventors:
Mintze Liong, Ying-Chieh Tsai, Matthew Cheeyuen Gan, Sawibah Yahya, Sybing Choi, Jiasin Ong, Waiyee Low, Chih-Chieh Hsu, Yi-Shan Lee
Abstract: Provided are compositions and methods for identifying a specific strain of Lactobacillus plantarum, e.g., Lactobacillus plantarum subsp. plantarum PS128 deposited under DSMZ Accession No. DSM 28632.
Abstract: The invention surprisingly found that Lactobacillus plantarum subsp. plantarum PS128 provides an advantageous effect in treatment or prevention of tic disorders and basal ganglia disorders. Accordingly, the invention provides a method of treating or preventing a movement disorder in a subject, comprising administering to a subject an effective amount of cells of a Lactobacillus plantarum subsp. plantarum PS128, which is deposited under DSMZ Accession No. DSM 28632.
Type:
Grant
Filed:
July 19, 2016
Date of Patent:
March 29, 2022
Assignees:
BENED BIOMEDICAL CO., LTD., ASIAN PROBIOTICS AND PREBIOTICS CORPORATION
Abstract: Provided is a method for preventing or treating an emotional or behavioral problem in a non-human animal, such as fears, phobias, anxieties and aggression, by administering a lactic acid bacterium the non-human animal in need thereof
Abstract: This disclosure provides a method of protecting a subject for exercise that prevents an exercise-related harmful effect and reducing exercise fatigue in the subject to thereby enhance physical performance and promote anti-fatigue and anti-inflammatory effects in the subject.
Abstract: An isolated and purified lactic acid bacteria is provided, which is Lactobacillus paracasei PS23 (PS23) and its applications in delaying aging process, improving immunomodulatory activity, reducing, preventing or treating allergic and inflammation, preventing or treating a chronic disorder and/or (vi) preventing and/or treating a mood disorder or a neurological condition.